Biomarkers in veterinary cancer screening: Applications, limitations and expectations.
The identification of biomarkers that distinguish diseased from normal individuals is of intense interest in many health-related fields. Potential applications for biomarkers in veterinary oncology include diagnosis, staging, prognosis and monitoring responses to therapy. By definition, effective biomarkers for cancer screening facilitate disease identification in sub-clinically affected patients and lead to subsequent improvements in clinical outcome. Although the methods and techniques of biomarker discovery and clinical application are translatable from humans to animals, veterinary medicine has lagged behind its human counterpart in several areas. Veterinarians have previously had a flawed understanding of how to use biomarker assays appropriately and have not had the positive influence on product research and development that could advance this field. The controversies, potentials biases, and considerations relative to the clinical application of biomarker assays for cancer screening are discussed in this review.
Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA. HenryC@missouri.edu
Carolyn J
CJ
Henry
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis*; D018450:Disease Progression; D055088:Early Detection of Cancer / Q000662:veterinary*; D008495:Medical Oncology / Q000639:trends*; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy / Q000662:veterinary*; D011379:Prognosis; D014730:Veterinary Medicine / Q000639:trends*
D014408:Biomarkers, Tumor